New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 8, 2014
08:24 EDTTKMRTekmira Ebola drug could see emergency use in U.S., says Maxim
Maxim said the FDA's decision to change its full clinical hold on TKM-Ebola to a partial hold paves the way for potential emergency use of the drug in the U.S., if needed. Maxim noted that Tekmira's DOD contract for development of the treatment is initially worth $140M, adding that the firm expect Tekmira to receive a government supplier contract by 2018 for the drug. Maxim keeps its Buy rating and $23 price target on the stock.
News For TKMR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 30, 2015
14:05 EDTTKMRPatient at UC Davis Medical center tests negative for Ebola, WSJ reports
Subscribe for More Information
January 29, 2015
13:51 EDTTKMRPotential Ebola patient being treated at UC Davis Medical Center, KCRA says
Subscribe for More Information
January 25, 2015
13:57 EDTTKMRUK nurse make full recovery from Ebola, WSJ says
Subscribe for More Information
January 23, 2015
10:07 EDTTKMRHigh option volume stocks
High option volume stocks: CE TSM RYAM NOC SNE FXCM LBTYA TKMR LF STT
January 22, 2015
16:41 EDTTKMRFalcon Edge Capital reports 9/9% passive stake in Tekmira
Subscribe for More Information
09:54 EDTTKMRTekmira mentioned cautiously by TheStreetSweeper
Subscribe for More Information
January 21, 2015
08:34 EDTTKMRTekmira initiates Phase I clinical trial of TKM-HBV
Subscribe for More Information
January 20, 2015
17:09 EDTTKMRRA Capital reports 9.9% passive stake in Tekmira
Subscribe for More Information
January 19, 2015
12:06 EDTTKMRNeurovive: Merger between Oncore and Tekmira includes NVP018 development
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use